334 related articles for article (PubMed ID: 30171053)
1. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA
Sakai S; Ohhata T; Kitagawa K; Uchida C; Aoshima T; Niida H; Suzuki T; Inoue Y; Miyazawa K; Kitagawa M
Cancer Res; 2019 Jun; 79(11):2821-2838. PubMed ID: 30952633
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
5. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
[TBL] [Abstract][Full Text] [Related]
6. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
8. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.
Zhou H; Kim YS; Peletier A; McCall W; Earp HS; Sartor CI
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):344-52. PubMed ID: 14751502
[TBL] [Abstract][Full Text] [Related]
9. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2-mediated EGFR-signaling is required for TGFβ-induced lens epithelial-mesenchymal transition.
Shu DY; Wojciechowski M; Lovicu FJ
Exp Eye Res; 2019 Jan; 178():108-121. PubMed ID: 30290164
[TBL] [Abstract][Full Text] [Related]
12. TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis.
Deng C; Lin YX; Qi XK; He GP; Zhang Y; Zhang HJ; Xu M; Feng QS; Bei JX; Zeng YX; Feng L
Cancer Res; 2018 Jul; 78(13):3469-3483. PubMed ID: 29735548
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis.
Hinz N; Baranowsky A; Horn M; Kriegs M; Sibbertsen F; Smit DJ; Clezardin P; Lange T; Schinke T; Jücker M
Cells; 2021 Feb; 10(2):. PubMed ID: 33670586
[TBL] [Abstract][Full Text] [Related]
14. Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.
Ferreira RB; Wang M; Law ME; Davis BJ; Bartley AN; Higgins PJ; Kilberg MS; Santostefano KE; Terada N; Heldermon CD; Castellano RK; Law BK
Oncotarget; 2017 Apr; 8(17):28971-28989. PubMed ID: 28423644
[TBL] [Abstract][Full Text] [Related]
15. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
16. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
17. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
19. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
20. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
